Most Recent
Finder Wallet has argued it did not need a financial services licence to sell its crypto product Finder Earn because it was not money, but instead allowed customers to purchase an asset and acted as a marketing tool to funnel users to its app.
A failed class action against Volkswagen over Takata airbags is seeking special leave from the High Court, arguing an appeals court was wrong to find a reasonable consumer would be comfortable with an airbag that posed a potential risk of rupture.
AMP and a group of financial advisers in a class action over changes to the firm's buyer of last resort policy have agreed to another round of mediation, even as the wealth manager appeals a judge's liability finding.
A former Greenwoods & Herbert Smith Freehills partner who claims he was sacked for complaining about Lendlease's attempts to avoid tax liability has asked the High Court to overrule a judgment finding recent changes to whistleblower protections do not apply retrospectively to cover his claims.
Global cryptocurrency and gambling website Stake.com is fighting to strike out claims in a lawsuit by Sydney-based online investment platform Stake over a planned Australian launch.
A former employee has brought proceedings against Woolworths, claiming the supermarket giant failed to properly address alleged sexual harassment in its “poor workplace culture".
The corporate regulator has again initiated proceedings against Gold Coast-based BHF Solutions and Cigno for allegedly providing credit without a licence after the lenders failed to convince the Full Court that their services fell outside the scope of the Credit Act.
Pathology giant Australian Clinical Labs has proposed a divestiture of collection centres amid competition concerns about its proposed takeover of competitor Healius, the owner of Dorevitch Pathology.
The Australian Securities and Investments Commission has filed an appeal after a judge ordered ACBF Funeral Plans to pay $1.2 million for misleading its First Nations customers, less than one-fifth of what the regulator sought.
Livestock drug company Zoetis has agreed to accept a $2.1 million payout to cover its costs in successfully defending a class action dubbed "totally off the planet" by a judge.